COA/RT-2026-117Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 40 mg
RT-2026-117Lot ALRT01Analyzed November 14, 2026
Timeline
Ordered
November 10, 2026
Received
November 13, 2026
Analyzed
November 14, 2026
Sample
Name
Retatrutide 40 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
Katerinne l
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
45.86mg
Label claim: 40 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.
Chromatogram
HPLC-UV
17.91 min, Retatrutide, >99.9%
Analyst Comments
White lyophilized powder, yellow-cap vial labeled CRT3, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 14, 2026
Verification Code
RT-SNN1-DHWQ
Verify at purilab.org/verify/RT-SNN1-DHWQ
Scan to Verify
RT-SNN1-DHWQ
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1